CML therapy

Details for Australian Patent Application No. 2004242456 (hide)

Owner Schering Corporation

Inventors Rose, Esther Helen; Rybak, Mary Ellen

Agent Griffith Hack

Pub. Number AU-A-2004242456

Parent 777456

Filing date 23 December 2004

Wipo publication date 20 January 2005

Acceptance publication date 15 February 2007

International Classifications

A61K 038/21 Medicinal preparations containing peptides - Interferons

A61P 035/02 Antineoplastic agents

Event Publications

13 January 2005 Complete Application Filed

20 January 2005 Application Open to Public Inspection

  Published as AU-A-2004242456

15 February 2007 Application Accepted

  Published as AU-A-2004242456

14 June 2007 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004242457-Macromolecular compounds

2004242455-Architecture for controlling access to a service by concurrent clients